Key result
Premedication with /kg melatonin provided preoperative anxiolysis and sedation without the cognitive and psychomotor impairment associated with midazolam.
Why the study?
Does sublingual melatonin or midazolam improve perioperative anxiety and sedation without psychomotor impairment in women undergoing standard anesthetic?
RCT (n=84)
double-blinded
randomized
Does sublingual melatonin or midazolam improve perioperative anxiety and sedation without psychomotor impairment in women undergoing standard anesthetic?
Sublingual melatonin at 0.05 mg/kg provides effective preoperative anxiolysis and sedation without the psychomotor impairment associated with midazolam.
This is the authors' abstract. We don't add key points for this paper.
We designed this prospective, randomized, double-blinded, placebo-controlled study to compare the perioperative effects of different doses of melatonin and midazolam. Doses of 0.05, 0.1, or 0.2 mg/kg sublingual midazolam or melatonin or placebo were given to 84 women, approximately 100 min before a standard anesthetic. Sedation, anxiety, and orientation were quantified before, 10, 30, 60, and 90 min after premedication, and 15, 30, 60, and 90 min after admission to the recovery room. Psychomotor performance of the patient was evaluated at these times also, by using the digit-symbol substitution test and Trieger dot test. Patients who received premedication with either midazolam or melatonin had a significant decrease in anxiety levels and increase in levels of sedation preoperatively compared with control subjects. Patients in the three midazolam groups experienced significant psychomotor impairment in the preoperative period compared with melatonin or placebo. After operation, patients who received 0.2 mg/kg midazolam premedication had increased levels of sedation at 90 min compared with 0.05 and 0.1 mg/kg melatonin groups. In addition, patients in the three midazolam groups had impairment of performance on the digit-symbol substitution test at all times compared with the 0.05 mg/kg melatonin group. Premedication with 0.05 mg/kg melatonin was associated with preoperative anxiolysis and sedation without impairment of cognitive and psychomotor skills or affecting the quality of recovery. Implications Premedication with 0.05 mg/kg melatonin was associated with preoperative anxiolysis and sedation without impairment of cognitive and psychomotor skills or affecting the quality of recovery.
Answers are grounded in this paper and cite their sources.
Low-dose melatonin may provide anxiolysis without psychomotor impairment; leaves open its comparative role versus midazolam in broader populations.
No takes yet. Share an insight, caveat, or question.
Naguib et al. (2000) conducted an RCT in Premedication for standard anesthetic (n=84). Melatonin vs. Midazolam (0.05, 0.1, or 0.2 mg/kg sublingual) or placebo was evaluated on Sedation, anxiety, orientation, and psychomotor performance. Premedication with /kg melatonin provided preoperative anxiolysis and sedation without the cognitive and psychomotor impairment associated with midazolam.
Synapse has enriched 10 related papers. Consider them for comparative context: